Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2pCh5Hj
via IFTTT